Henry Gosebruch
Chief Executive Officer chez NEUMORA THERAPEUTICS, INC.
Fortune : 9 M $ au 31/12/2023
Profil
Henry O.
Gosebruch is currently the President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. and a Director at ACELYRIN, Inc. Previously, he served as an Independent Director at Aptinyx, Inc. from 2019 to 2023.
Prior to that, he was the Chief Strategy Officer & Executive Vice President at AbbVie, Inc. from 2015 to 2023 and Co-Head of Mergers & Acquisitions North America at JPMorgan Securities LLC from 1995 to 2015.
He received his undergraduate degree from The Wharton School of the University of Pennsylvania in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/02/2024 | 604 793 ( 0,38% ) | 8 M $ | 31/03/2024 | |
ACELYRIN, INC.
0,05% | 09/05/2023 | 50 000 ( 0,05% ) | 337 500 $ | 31/03/2024 |
APTINYX INC
0,18% | 24/04/2023 | 125 000 ( 0,18% ) | 12 000 $ | 31/12/2023 |
Postes actifs de Henry Gosebruch
| Sociétés | Poste | Début |
|---|---|---|
| ACELYRIN, INC. | Director/Board Member | 29/03/2023 |
| NEUMORA THERAPEUTICS, INC. | Chief Executive Officer | 18/07/2023 |
Anciens postes connus de Henry Gosebruch
| Sociétés | Poste | Fin |
|---|---|---|
| APTINYX | Director/Board Member | 04/05/2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01/02/2023 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/12/2015 |
Formation de Henry Gosebruch
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| APTINYX | Health Technology |
| ACELYRIN, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
